PALI
Palisade Bio, Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 9:30:01 AM EST
0.95USD+1.253%(+0.01)5
Pre-marketNov 19, 2026 8:56:30 AM EST
0.99USD+5.084%(+0.05)
PALI News
Palisade Bio GAAP EPS of -$0.07 misses by $0.01 ·
Seeking Alpha
Palisade Bio doses first patient in ulcerative colitis trial ·
Investing.com
Oppenheimer reiterates Palisade Bio stock rating on Crohn’s data ·
Investing.com
H.C. Wainwright reiterates Palisade Bio stock rating at buy ·
Investing.com
Palisade Bio presents clinical data on ulcerative colitis drug ·
Investing.com
Palisade Bio director buys $28,800 in PALI stock ·
Investing.com
Palisade Bio stock initiated at Outperform by Raymond James ·
Investing.com
Palisade Bio at Stifel forum: pde4 bet advances into phase 2 ·
Investing.com
Palisade Bio to Present at Stifel 2026 Virtual Immunology and Inflammation Forum ·
GlobeNewswire Inc.